p53 and microvessel density in primary resection specimens of superficial bladder cancer

Journal of Urology

Volumn 167, Issue 3, 2002, Pages 1469-1474

  Reiher, Frank ^a,b   Ozer, Ozden ^a,b   Pins, Michael ^a,b   Jovanovic, Borko D ^a,b   Eggener, Scott ^a,b   Campbell, Steven C ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

Bladder; Bladder neoplasms; Genes, p53; Neovascularization; Pathologic

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; PROTEIN P53;

ANGIOGENESIS; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DENSITY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROGNOSIS; REGULATORY MECHANISM; SUPERFICIAL CANCER;

EID: 0036160594     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65347-5     Document Type: Article

References (39)

1. How tumors become angiogenic
2. The role of angiogenesis in tumor growth
3. Tumor angiogenesis
4. Cancer statistics, 1997
5. Angiogenesis in bladder cancer
6. Advances in angiogenesis research: Relevance to urological oncology
7. Fluorescein angiography of the bladder: Technique and relevance to bladder cancer and interstitial cystitis patients
8. Angiogenesis inhibitor TNP-470 suppresses tumorigenesis in rat urinary bladder
9. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-α administration
10. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer
11. Angiogenesis in bladder cancer: Relationship between microvessel density and tumor prognosis
12. The pathophysiology of angiogenesis
13. Molecular mediators of angiogenesis in bladder cancer
14. Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity
15. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein
16. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein
17. Modulation of hypoxia-inducible factor 1 alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
18. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer
19. Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis, and tumor progression
20. Regulation of angiogenesis in bladder cancer: Role of p53 and hypoxia
21. Immunohistochemical evaluation of biomarkers in prostatic and colorectal neoplasia
22. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
23. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation
24. P53 mutations in human bladder cancer: Genotypic vs. phenotypic patterns
25. P53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer
26. Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder
27. Two molecular pathways to transitional cell carcinoma of the bladder
28. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression
29. Accumulation of nuclear p53 and tumor progression in bladder cancer
30. p53, The cellular gatekeeper for growth and division
31. Presence and location of p53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer
32. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers
33. Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors
34. Control of the growth of human bladder cancer by a thrombospondin-1 mimetic
35. Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer
36. Bladder cancer: Molecular progression to invasive disease
37. Molecular genetics of bladder cancer